Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Orthostatic Intolerance: early-phase trial registry

3 of 6 indexed Orthostatic Intolerance trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Orthostatic Intolerance: 6 US clinical trials tracked, 3 recruiting.

Orthostatic Intolerance is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Satish R. Raj, running 1 of these trials.

Enrollment posture brief

Registry condition orthostatic-intolerance

OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Orthostatic Intolerance (thi…50%
Open-enrollment share among volume-matched conditions near Orthostatic Intolerance

Orthostatic Intolerance lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Orthostatic Intolerance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Orthostatic Intolerance is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Orthostatic Intolerance research.

    Satish R. Raj accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Orthostatic Intolerance enrolment sits around 100 participants.

    Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Orthostatic Intolerance splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Orthostatic Intolerance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

17β-Oestradiol Drug
1 trials
Ganirelix acetate Drug
1 trials
Actigraphy Watch (motion sensors) with light sensors - ActiWatch from Minimitter Device
1 trials
normal saline (0.9%) Other
1 trials
Development of AD/OI after BS Other
1 trials
Angioplasty or stenting Device
1 trials
Progesterone Drug
1 trials
LBNP + Isometric handgrip exercise Other
1 trials

US sites by state

Facility locations filed on Orthostatic Intolerance trials. A trial with sites in several states counts in each.

Tennessee 2 trials
New York 1 trials
Missouri 1 trials
Massachusetts 1 trials
Kansas 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Orthostatic Intolerance page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Orthostatic Intolerance trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Satish R. Raj sponsors the most Orthostatic Intolerance trials on record, review their full trial history before evaluating a specific study. See Satish R. Raj's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Orthostatic Intolerance condition card totals 6 registered trials; most-linked intervention 17β-Oestradiol; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.